HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gail A Bishop Selected Research

TNF Receptor-Associated Factor 3

1/2021TRAF3 in T Cells Restrains Negative Regulators of LAT to Promote TCR/CD28 Signaling.
1/2021Multiple mechanisms for TRAF3-mediated regulation of the T cell costimulatory receptor GITR.
1/2021TNF receptor-associated factor 3 restrains B-cell receptor signaling in normal and malignant B cells.
1/2019TRAF3 regulates the oncogenic proteins Pim2 and c-Myc to restrain survival in normal and malignant B cells.
1/2018TRAF3 as a Multifaceted Regulator of B Lymphocyte Survival and Activation.
12/2017The oncogenic membrane protein LMP1 sequesters TRAF3 in B-cell lymphoma cells to produce functional TRAF3 deficiency.
10/2016TRAF3 deficiency promotes metabolic reprogramming in B cells.
1/2016Nuclear TRAF3 is a negative regulator of CREB in B cells.
9/2015The adaptor protein TRAF3 inhibits interleukin-6 receptor signaling in B cells to limit plasma cell development.
7/2015TRAF3, ubiquitination, and B-lymphocyte regulation.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gail A Bishop Research Topics

Disease

17Neoplasms (Cancer)
11/2021 - 01/2007
9Infections
01/2021 - 10/2007
5Lymphoma (Lymphomas)
01/2021 - 11/2010
5Autoimmune Diseases (Autoimmune Disease)
01/2020 - 07/2007
5Multiple Myeloma
12/2017 - 01/2013
4Splenomegaly
01/2020 - 08/2004
4Inflammation (Inflammations)
01/2020 - 11/2010
4B-Cell Lymphoma (Lymphoma, B Cell)
12/2017 - 03/2011
3Lymphadenopathy
10/2009 - 08/2004
2Insulin Resistance
01/2015 - 08/2014
2Hyperplasia
11/2010 - 08/2007
2Arthritis (Polyarthritis)
11/2010 - 07/2007
1Melanoma (Melanoma, Malignant)
11/2021
1Breast Neoplasms (Breast Cancer)
01/2021
1Vesicular Stomatitis
01/2021
1Glomerulonephritis
01/2020
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2020
1Septic Shock (Toxic Shock Syndrome)
01/2019
1Communicable Diseases (Infectious Diseases)
01/2019
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2019
1Myeloid Leukemia (Leukemia, Myelocytic)
11/2016
1Diarrhea
04/2016
1Obesity
08/2014
1Latent Infection
01/2014
1Respiratory Hypersensitivity
11/2010
1Pneumonia (Pneumonitis)
11/2010
1Eosinophilia
11/2010
1Asthma (Bronchial Asthma)
11/2010
1Hypergammaglobulinemia (Hyperimmunoglobulinemia)
08/2007
1Persistent Infection
11/2004
1Necrosis
10/2004

Drug/Important Bio-Agent (IBA)

15TNF Receptor-Associated Factor 3IBA
01/2021 - 11/2004
8Membrane Proteins (Integral Membrane Proteins)IBA
12/2017 - 07/2007
6Proteins (Proteins, Gene)FDA Link
01/2021 - 10/2004
3AutoantibodiesIBA
01/2020 - 08/2004
2AntigensIBA
11/2021 - 02/2008
2Phosphotransferases (Kinase)IBA
01/2021 - 12/2014
2NucleotidesIBA
01/2019 - 01/2018
2Leucine (L-Leucine)FDA Link
01/2019 - 01/2018
2LigandsIBA
05/2015 - 02/2008
2ElementsIBA
08/2014 - 12/2008
2honokiolIBA
11/2010 - 07/2007
2Interleukin-6 (Interleukin 6)IBA
10/2009 - 08/2004
1B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA
11/2021
1Neoplasm Antigens (Tumor Antigens)IBA
11/2021
1VaccinesIBA
11/2021
1Cancer VaccinesIBA
11/2021
1Interleukin-12 (IL 12)IBA
01/2021
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2021
1Glycoproteins (Glycoprotein)IBA
01/2021
1Tyrosine (L-Tyrosine)FDA Link
01/2021
1CreatinineIBA
01/2020
1EBV-encoded nuclear antigen 1IBA
01/2020
1Antigen-Antibody Complex (Immune Complex)IBA
01/2020
1Antinuclear AntibodiesIBA
01/2020
1AutoantigensIBA
01/2020
1NitrogenIBA
01/2020
1Urea (Carbamide)FDA LinkGeneric
01/2020
1RNA (Ribonucleic Acid)IBA
01/2019
1Messenger RNA (mRNA)IBA
01/2019
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2019
1Glycogen Synthase Kinase 3IBA
01/2019
1ExotoxinsIBA
01/2019
1SuperantigensIBA
01/2019
1ChemokinesIBA
01/2019
1Enterotoxins (Enterotoxin)IBA
01/2019
1Chemotactic FactorsIBA
01/2018
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
12/2017
1Interleukin-2 Receptors (IL 2 Receptor)IBA
11/2016
1Nuclear Proteins (Protein, Nuclear)IBA
11/2016
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2016
1Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA
11/2016
1TNF Receptor-Associated Factor 2 (TRAF2)IBA
04/2016
1Insulin (Novolin)FDA Link
01/2015
1Protein Isoforms (Isoforms)IBA
12/2014
1piperlongumineIBA
07/2013
1Toll-Like Receptor 7IBA
08/2012
1Immunoglobulin G (IgG)IBA
01/2011
1TNF Receptor-Associated Factor 6 (TRAF6)IBA
11/2010
1CollagenIBA
11/2010
1Neurotransmitter Agents (Neurotransmitter)IBA
11/2010
1Aminobutyrates (Aminobutyric Acid)IBA
11/2010
1CytokinesIBA
11/2010
1Methacholine Chloride (Methacholine)FDA Link
11/2010
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
11/2010
1Neurotransmitter Receptors (Neurotransmitter Receptor)IBA
11/2010
1TNF Receptor-Associated Factor 5IBA
12/2008
1Biological ProductsIBA
10/2007

Therapy/Procedure

4Therapeutics
01/2019 - 08/2014